FDA Pauses Clozapine REMS Program Enforcement Due to High Volume of Patient Delays
The program was put in place to prevent cases of neutropenia, which was leaving patients vulnerable to severe and sometimes deadly infections.
The program was put in place to prevent cases of neutropenia, which was leaving patients vulnerable to severe and sometimes deadly infections.